Page results
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing and tissue diagnosis.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
The department specialises in the assessment and management of complex neuropsychiatric conditions occurring in the context of neurological disease.
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
This page provides information for patients visiting the Inflammatory Bowel Disease clinic.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
-
This information outlines the things that you need to take home after your robotic prostatectomy.
File results
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication